Symbol Name ID |
Cntn2
contactin 2 MGI:104518 |
Reference
|
J:283402 Kastriti ME, Stratigi A, Mariatos D, Theodosiou M, Savvaki M, Kavkova M, Theodorakis K, Vidaki M, Zikmund T, Kaiser J, Adameyko I, Karagogeos D, Ablation of CNTN2+ Pyramidal Neurons During Development Results in Defects in Neocortical Size and Axonal Tract Formation. Front Cell Neurosci. 2019;13:454 |
Age | E11.5 | E12.5 | E13.5 | E15.5 | E17.5 | P |
Immunohistochemistry (section) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
In situ RNA (section) | ||||||
Immunohistochemistry (whole mount) | ||||||
In situ RNA (whole mount) | ||||||
In situ reporter (knock in) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Northern blot | ||||||
Western blot | ||||||
RT-PCR | ||||||
cDNA clones | ||||||
RNase protection | ||||||
Nuclease S1 | ||||||
Primer Extension |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/24/2024 MGI 6.24 |
![]() |
|